08.26.25 -- Multi-Indication Strategies Reshape Immunology's R&D Strategy

See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

As injectable therapies revolutionize cancer treatment, choosing the right CDMO can help early-stage developers navigate increasing pressures and complex formulation and manufacturing challenges.

Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

When facing a malfunction, having an effective disaster recovery plan can make the difference between a swift fix, and losing your samples and time.

Experts share how to minimize the number of animals used in toxicology studies while ensuring robust and reproducible findings, including the advantages and limitations of each method.

Stable bulk cultures, made highly uniform using transposase-mediated technologies, may be the key to expediting clone selection for many biopharmaceutical applications.